Radioactive iodine in low- to intermediate-risk papillary thyroid cancer

It remains controversial whether papillary thyroid cancer (PTC) patients with low- to intermediate-risk disease should receive radioactive iodine (RAI) after total thyroidectomy (TT). We aim to identify those who might benefit from RAI treatment in PTC patients with cervical nodal metastasis after T...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Hengqiang, Gong, Yiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402902/
https://www.ncbi.nlm.nih.gov/pubmed/36034423
http://dx.doi.org/10.3389/fendo.2022.960682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402902/
https://www.ncbi.nlm.nih.gov/pubmed/36034423
http://dx.doi.org/10.3389/fendo.2022.960682

Ejemplares similares